The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment. [PDF]
Herold S +13 more
europepmc +1 more source
Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction [PDF]
Attygalle, AD +8 more
core +1 more source
Real-world treatment patterns of Bruton tyrosine kinase inhibitors in mantle cell lymphoma in a community oncology setting. [PDF]
Shah BD, Xue M, Furnback W, Yang K.
europepmc +1 more source
KSHV- and EBV-associated germinotropic lymphoproliferative disorder [PDF]
Cabecadas, J +11 more
core +1 more source
AIIMS Mantle Cell Lymphoma Overall Survival (AMOS) & AIIMS Mantle Cell Lymphoma Event-Free Survival (AMES) scores: Development of novel indigenous survival prediction models & risk stratification for mantle cell lymphoma in the Indian population. [PDF]
Datta S, Gogia A, Wig N, Pandey S.
europepmc +1 more source
We are on the right track for mantle cell lymphoma. [PDF]
Moioli A, Visco C.
europepmc +1 more source
Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions. [PDF]
Tiwari B, Afshan R, Sridhar S.
europepmc +1 more source
Transcriptional Analysis of Effusion-Based Lymphoma Supports a Post-Germinal Center Origin and Specific Inflammatory Signal Background. [PDF]
Perez-Silos V +13 more
europepmc +1 more source
Case Report: Membranous nephropathy associated with mantle cell lymphoma: a rare case. [PDF]
Ren M, Cao L, Shen Q, Zhu B, Wu J.
europepmc +1 more source

